GMPs, QA & QC

AHPA's McGuffin on DSHEA 2.0, CBD's path forward, and more

AHPA's McGuffin on DSHEA 2.0, CBD's path forward, and more

By Stephen Daniells

While AHPA supports H.R.841, the association wishes FDA “would do its job and establish a legal pathway [for hemp and CBD], but they haven’t,” said Michael McGuffin. “Something needs to happen.”

CRN’s Mister on the best solution for CBD, DSHEA 2.0, and more

CRN’s Mister on the best solution for CBD, DSHEA 2.0, and more

By Stephen Daniells

The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act represents ‘the best way’ to deal with the hemp-CBD issue for dietary supplements, says CRN’s Steve Mister, and once that’s clarified then the FDA and industry can address...

NutraCast: Compliance amid a pandemic with CRO NutraSource

NutraCast: Compliance amid a pandemic with CRO NutraSource

By Danielle Masterson

Nutrasource, a Canada-based contract research organization, quickly adapted to the pandemic by implementing regulations and best practices to continue running human trials. The company’s president and CEO, Will Rowe, and Josh Baisley, VP of clinical...

Follow us

Products

View more

Webinars